Assessing Safety of Anticoagulation for Atrial Fibrillation in Patients with Cirrhosis: A Real-World Outcomes Study

By sjmartinez • July 27, 2024

Song JJ, Jackson NJ, Shang H, Honda HM, Boulier K. Assessing Safety of Anticoagulation for Atrial Fibrillation in Patients with Cirrhosis: A Real-World Outcomes Study. J Cardiovasc Pharmacol Ther. 2024 Jan-Dec;29:10742484241256271. doi: 10.1177/10742484241256271. PMID: 39053441.

Tags: Anticoagulation, atrial fibrillation, Cardiology/Epi, Cirrhosis, Fellow, General Internal Medicine, Hematology/Oncology, Publications, Resident, safety outcomes

Efficacy and Toxicity of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data

Murthy V, Voter AF, Nguyen K, Allen-Auerbach M, Chen L, Caputo S, Ledet E, Akerele A, Tuchayi AM, Lawhn-Heath C, Wang T, Carducci MA, Pomper[...]

Response to “Epicardial fat tissue and diastolic dysfunction in both men and women with HIV”

Goldberg RL, Peterson TE, Haberlen SA, Witt MD, Palella FJ, Magnani JW, Brown TT, Lake JE, Lima JAC, Budoff MJ, Ndumele CE, Wu KC, Post[...]

Comparative analysis of two independent Myh6-Cre transgenic mouse lines

Davenport A, Kessinger CW, Pfeiffer RD, Shah N, Xu R, Abel ED, Tucker NR, Lin Z. Comparative analysis of two independent Myh6-Cre transgenic mouse lines.[...]